News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,598 Results
Type
Article (23137)
Company Profile (30)
Press Release (359427)
Multimedia
Podcasts (131)
Webinars (15)
Section
Business (119035)
Career Advice (1431)
Deals (17345)
Drug Delivery (74)
Drug Development (42182)
Employer Resources (97)
FDA (8801)
Job Trends (8402)
News (190003)
Policy (17075)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1466)
Academic (1)
Accelerated approval (26)
Adcomms (16)
Allergies (114)
Alliances (33159)
ALS (138)
Alzheimer's disease (1071)
Antibody-drug conjugate (ADC) (292)
Approvals (9164)
Artificial intelligence (469)
Autoimmune disease (210)
Automation (40)
Bankruptcy (157)
Best Places to Work (6985)
BIOSECURE Act (6)
Biosimilars (136)
Biotechnology (25)
Bladder cancer (137)
Brain cancer (39)
Breast cancer (494)
Cancer (3894)
Cardiovascular disease (322)
Career advice (1240)
Career pathing (35)
CAR-T (179)
CDC (30)
Celiac Disease (1)
Cell therapy (586)
Cervical cancer (32)
Clinical research (37355)
Collaboration (1581)
Company closure (2)
Compensation (367)
Complete response letters (36)
COVID-19 (1511)
CRISPR (72)
C-suite (614)
Cystic fibrosis (85)
Data (5573)
Decentralized trials (3)
Denatured (46)
Depression (106)
Dermatology (59)
Diabetes (400)
Diagnostics (3743)
Digital health (35)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (218)
Drug pricing (105)
Drug shortages (21)
Duchenne muscular dystrophy (189)
Earnings (59513)
Editorial (50)
Employer branding (12)
Employer resources (85)
Events (58797)
Executive appointments (603)
FDA (11272)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (27)
Funding (995)
Gene editing (150)
Generative AI (49)
Gene therapy (499)
GLP-1 (652)
Government (2406)
Grass and pollen (6)
Guidances (345)
Healthcare (10253)
HIV (60)
Huntington's disease (36)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (67)
Immunology and inflammation (169)
Immuno-oncology (67)
Indications (146)
Infectious disease (1707)
Inflammatory bowel disease (146)
Inflation Reduction Act (12)
Influenza (77)
Intellectual property (175)
Interviews (270)
IPO (8376)
IRA (30)
Job creations (1719)
Job search strategy (999)
JPM (44)
Kidney cancer (11)
Labor market (60)
Layoffs (257)
Leadership (33)
Legal (4408)
Liver cancer (53)
Longevity (19)
Lung cancer (523)
Lymphoma (309)
Machine learning (34)
Management (33)
Manufacturing (656)
MASH (143)
Medical device (6884)
Medtech (6956)
Mergers & acquisitions (9782)
Metabolic disorders (1002)
mRNA (127)
Multiple sclerosis (132)
NASH (9)
Neurodegenerative disease (257)
Neuropsychiatric disorders (61)
Neuroscience (2019)
NextGen: Class of 2026 (3420)
Non-profit (2715)
Now hiring (12)
Obesity (437)
Opinion (210)
Ovarian cancer (130)
Pain (156)
Pancreatic cancer (182)
Parkinson's disease (228)
Partnered (21)
Patents (342)
Patient recruitment (355)
Peanut (33)
People (28521)
Pharmaceutical (9)
Pharmacy benefit managers (18)
Phase 1 (11202)
Phase 2 (15922)
Phase 3 (13307)
Pipeline (6569)
Policy (178)
Postmarket research (1639)
Preclinical (4952)
Press Release (31)
Prostate cancer (258)
Psychedelics (33)
Radiopharmaceuticals (198)
Rare diseases (694)
Real estate (2581)
Recruiting (38)
Regulatory (13499)
Reports (23)
Research institute (1373)
Resumes & cover letters (218)
Rett syndrome (26)
RNA editing (14)
RSV (53)
Schizophrenia (114)
Series A (179)
Series B (106)
Service/supplier (3)
Sickle cell disease (81)
Special edition (14)
Spinal muscular atrophy (82)
Sponsored (30)
Startups (1520)
State (1)
Stomach cancer (11)
Supply chain (64)
Tariffs (39)
The Weekly (84)
Vaccines (653)
Venture capital (61)
Weight loss (268)
Women's health (73)
Worklife (15)
Date
Today (48)
Last 7 days (412)
Last 30 days (2269)
Last 365 days (19211)
2026 (8314)
2025 (19005)
2024 (20194)
2023 (22239)
2022 (28000)
2021 (29822)
2020 (29129)
2019 (25095)
2018 (18576)
2017 (17501)
2016 (17037)
2015 (19389)
2014 (16256)
2013 (14243)
2012 (14064)
2011 (13505)
2010 (12696)
Location
Africa (551)
Alabama (65)
Alaska (4)
Arizona (156)
Arkansas (8)
Asia (22305)
Australia (3685)
California (7954)
Canada (2298)
China (838)
Colorado (373)
Connecticut (410)
Delaware (254)
Europe (52566)
Florida (1295)
Georgia (272)
Hawaii (1)
Idaho (25)
Illinois (613)
India (65)
Indiana (436)
Iowa (10)
Japan (362)
Kansas (79)
Kentucky (22)
Louisiana (15)
Maine (35)
Maryland (986)
Massachusetts (5797)
Michigan (236)
Minnesota (359)
Mississippi (2)
Missouri (66)
Montana (11)
Nebraska (9)
Nevada (88)
New Hampshire (37)
New Jersey (2512)
New Mexico (14)
New York (2225)
North Carolina (1050)
North Dakota (6)
Northern California (3924)
Ohio (209)
Oklahoma (16)
Oregon (19)
Pennsylvania (1751)
Puerto Rico (10)
Rhode Island (26)
South America (753)
South Carolina (35)
Southern California (3283)
Tennessee (150)
Texas (1289)
United States (28980)
Utah (264)
Vermont (1)
Virginia (185)
Washington D.C. (52)
Washington State (641)
West Virginia (2)
Wisconsin (67)
Wyoming (2)
382,598 Results for "frost and sullivan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
L7 Informatics Named Top Innovator in 2025 Frost & Sullivan Frost Radar™ for Pharma and Biotech LIMS
October 31, 2025
·
3 min read
Press Releases
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry
November 20, 2025
·
5 min read
Press Releases
Decorated Senior Army Officer Tal Sullivan Joins Battelle
February 19, 2026
·
2 min read
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan
WuXi AppTec received the 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan, a growth advisory & growth opportunity analytics firm.
November 8, 2023
·
2 min read
Press Releases
Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
February 18, 2026
·
3 min read
Frost & Sullivan white paper highlights the role of SmartRotate™ in improving radiography workflows
Image rotations were reduced by up to 91% according to Frost & Sullivan’s study of two hospitals using Agfa’s AI.
June 12, 2023
·
5 min read
Pharm Country
Curia wins 2023 Frost & Sullivan Customer Value Leadership Award
Curia, a leading contract research, development and manufacturing organization, announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.
June 29, 2023
·
2 min read
Press Releases
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
September 16, 2024
·
2 min read
Business
Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services
September 11, 2024
·
3 min read
BioCapital
Adial Pharmaceuticals Wins Frost & Sullivan’s 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award
Adial Pharmaceuticals, Inc. announced that it has been awarded the 2023 Best Practices Technology Innovation Leadership Award in the North American precision medicine for addiction disorders industry by Frost & Sullivan, an American business consulting firm that offers market research and analysis, growth strategy consulting, and corporate training.
October 18, 2023
·
6 min read
1 of 38,260
Next